Form Type: 4

SEC EDGAR Link
Accession Number:0001179110-20-007163
Date:2020-06-09
Issuer: CELLDEX THERAPEUTICS, INC. (CLDX)
Original Submission Date:

Reporting Person:

MARUCCI ANTHONY S
C/O CELLDEX THERAPEUTICS, INC.
53 FRONTAGE ROAD HAMPTON, NJ 08827

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK, PAR VALUE $0.001 PER SHARE 2020-06-09 P 15,000 a $3.06 19,438 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 includes 1,103 shares of common stock acquired under the company's 2004 employee stock purchase plan.
WhaleWisdom Logo

Elevate your investments